| Financial Year |
March 31 2023 |
| Monetary Funds |
428,759,637.42 |
| Held-for-trading Financial Assets |
365,960,879.63 |
| Notes Receivable |
9,024,494.46 |
| Accounts Receivable |
732,214,002.20 |
| Advances to Suppliers |
47,816,095.84 |
| Other Receivables |
16,005,136.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,219,379,903.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,605,845.20 |
| Total Current Assets |
2,933,975,880.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
631,146,004.17 |
| Under-construction Projects |
134,338,725.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,275,362.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,226.84 |
| Deferred Income Tax Assets |
18,583,030.23 |
| Other Non-Current Assets |
50,724,797.13 |
| Sub-Total of Non-Current Assets |
999,966,175.99 |
| Total Assets |
3,933,942,056.96 |
| Short-Term Loans |
135,066,027.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
389,537,048.20 |
| Accounts Payable |
412,040,371.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,558,161.06 |
| Taxes Payable |
9,289,703.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,860,071.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
25,572,142.96 |
| Sub-Total of Current Liabilities |
1,197,476,234.57 |
| Long-term Loans |
55,054,722.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
894,131.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,943,984.02 |
| Total Liabilities |
1,281,420,218.59 |
| Paid-In Capital(Or Share Stock) |
400,758,848.00 |
| Capital Surplus |
903,301,326.21 |
| Surplus Reserve |
199,898,745.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,146,919,936.99 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,652,521,838.37 |
| Owner's Equity（Stockholder's Equity） |
2,652,521,838.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,933,942,056.96 |
